A breast cancer survivor describes how pathology informs diagnosis and treatment, and advocates for clearer communication between pathologists and patients.
Approach:
Diagnosis and treatment: The author explains that pathologists assess biopsy tissue to confirm cancer, determine its type and grade, and evaluate markers that guide treatment.
Patient experience: After viewing her tissue slides and discussing them with her pathologist, the author says she better understood her diagnosis and felt more involved in her care.
Advocacy: She describes patient-advocacy work at local, state, and national levels, including efforts to improve patient engagement, trial awareness, and understanding of pathology reports.
Key Findings:
The author says her Grade 2 invasive carcinoma diagnosis and subsequent care were informed by her pathology report.
She describes patient-facing pathology conversations and clinics as valuable ways to explain diagnoses.
She credits laboratory professionals with providing timely, accurate blood-test results used during chemotherapy.
Interpretation:
This is a first-person advocacy article, not a research study. The author argues that pathology and laboratory work are central to cancer care and that patients should be able to understand their diagnoses.
Limitations:
The article presents the author's personal experience and advocacy perspective.
It provides no study methods, quantitative outcomes, or comparative evidence for the effects of pathology clinics.
Conclusion:
The author encourages readers to get screened and ask questions, and thanks pathologists and laboratory professionals for their contributions to care.
